We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.



Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ


Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Listed on ASX ( $        )


Former (or subsequent) names


Shareholder links

Our website ranking of API: rating 5
(5 out of 5)



Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Level 5 250 Camberwell Road Camberwell VIC 3124 Australia
Tel:  (+61 3) 8855 3000 Fax: (+61 3) 8855 3402

Date first listed: 16/06/1997
Company Secretary: Peter Sanguinetti
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Wholesale distributor of pharmaceutical and allied products and retail support services to pharmacists
API has today announced that in preparation for the release of its half year results, it will incur an asset impairment charge of $131 million. Notwithstanding this non-cash charge, the underlying business performance is strong, with a net profit after tax of $16.2 million, subject to final auditor review, for the six months ended 28 February 2014 (up from $12.6 million for the prior comparable period). 17/04/2014
The suspension of trading in the securities of Australian Pharmaceutical Industries Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the carrying value of its assets. Security Code: API17/04/2014
The securities of Australian Pharmaceutical Industries Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the carrying value of its assets. Security Code: API 16/04/2014
shares reinstated to quotation22/08/2006
company advises that the Australian Securities & Investments Commission (ASIC) had granted the company an extension to lodge its Final Accounts on Monday 21 August 2006 - the Australian Stock Exchange (ASX) has advised that API shares will recommence trading the day following the Final Accounts being lodged with ASIC and the ASX18/08/2006
appoints new CEO, releases preliminary final report and Results for Year Ended 30 April 2006 and also a FY06 Results Presentation - the company has lost $17m but can't explain how or where14/08/2006
company advises that on Monday 14 August 2006 it will be releasing its full-year financial results for the year ended 30 April 2006. There will be a teleconference briefing held at 1 p.m. on 14 August. The teleconference can be accessed by calling: Dial in # 1800 097 137 Confirmation Code 506587211/08/2006
company advises that the Australian Securities & Investments Commission has granted the company an extension to enable the company to lodge its financial results and report for financial year 2006 on or by 14 August 200628/07/2006
the company today advised that while it had made progress on resolving a number of the issues delaying the release of its financial results, there are still some outstanding items that require further attention21/07/2006
shares suspended from quotation pending release of an announcement14/07/2006

ASX Announcements (courtesy of ASX)


Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    06/02/2018Mark Smith35,552 $1.405$49,951
    29/01/2018Kenneth Gunderson-Briggs10,000 $1.450$14,500
    25/01/2018Jennifer MacDonald35,000 $1.438$50,334
    25/01/2018Mark Smith34,448 $1.450$49,950
    23/11/2017Mark Smith10,000 $1.465$14,650

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Richard VincentManaging Director, CEO15/02/2017
    Carol HolleyIndependent Director19/12/2006
    Gerard MastersIndependent Director07/09/2010
    Kenneth Gunderson-BriggsIndependent Director06/05/2014
    Lee AusburnIndependent Director07/10/2008
    Robert MillnerNon Exec Director12/05/2000
    Mark SmithNon Exec Director06/09/2017
    Jennifer MacDonaldNon Exec Director09/11/2017
    Peter SanguinettiGeneral Counsel30/11/2007

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Peter RobinsonNon Exec Chairman05/05/200024/01/2018
    Stephen RocheManaging Director, CEO14/08/200615/02/2017
    Michael WooldridgeIndependent Director01/02/200631/12/2014
    Graeme FalletCFO24/08/200919/12/2014
    Miles HamptonIndependent Director07/08/200730/01/2014
    Barry FrostDeputy Chairman11/08/200631/07/2008
    David FairfullNon Exec Director05/05/200016/08/2007
    John MurphyNon Exec Director07/10/200407/08/2007
    Gregory RoberstonAlternate Director07/10/200407/08/2007
    Michael SmithNon Exec Director25/09/198121/08/2006
    Jeffrey SherExecutive07/10/200414/08/2006
    Graeme HerringNon Exec Director01/04/199708/06/2004
    Fritz HorlacherNon Exec Director21/04/2004
    Peter WrightNon Exec Director21/04/2004
    Frank ConroyChairman01/07/200108/07/2003
    Verilyn FitzgeraldNon Exec Director01/09/199708/07/2003

    Date of first appointment, title may have changed.